Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
about
Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cellsBeyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2.Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis.Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
P2860
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
@ast
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
@en
type
label
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
@ast
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
@en
prefLabel
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
@ast
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
@en
P2093
P2860
P356
P1476
Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
@en
P2093
Frank W Sellke
Roger J Laham
Tanveer A Khan
P2860
P304
P356
10.1517/14656566.4.2.219
P407
P577
2003-02-01T00:00:00Z